Long-term Maintenance of Remission with No Dose Escalation After Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation Who Were Naive to Anti-TNF Treatment: 4-Year Results from the PRECiSE 4 Study

被引：1

作者：

Sandborn, William ^{[1
]}

Schreiber, Stefan ^{[2
]}

Hanauer, Stephen ^{[3
]}

Colombel, Jean-Frederic ^{[4
]}

Bloomfield, Ralph ^{[5
]}

Lichtenstein, Gary ^{[6
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Univ Kiel, Kiel, Germany

[3] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[4] Hop Claude Huriez, Lille, France

[5] UCB Pharma, Slough, Berks, England

[6] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷

关键词：

D O I：

10.14309/00000434-201010001-01153

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1153

引用

页码：S418 / S418

页数：1

共 30 条

[1] Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 4-year results from PRECiSE 4.
Sandborn, W.
Schreiber, S.
Hanauer, S.
Colombel, J.
Bloomfield, R.
Lichtenstein, G.
[J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S60 - S60
[2] Sustained Remission With No Dose Escalation After Re-Induction With Certolizumab Pegol in Patients With Crohn's Disease Exacerbation Who Were NaiVE to Anti-TNF Treatment: 5-Year Results From Precise 4
Sandborn, William J.
Schreiber, Stefan
Colombel, Jean-Frederic
Sen, David L.
Lichtenstein, Gary R.
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S65 - S66
[3] Sustained remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation who were naive to anti-TNF treatment: 5-year results from PRECiSE 4
Sandborn, William J.
Schreiber, Stefan
Colombel, Jean-Frederic
Sen, David
Lichtenstein, Gary R.
[J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S24 - S24
[4] Long-term maintenance of remission with no dose escalation after re-induction with certolizumab pegol in patients with Crohn's disease exacerbation: 3-year results from the PRECiSE 4 study
Sandborn, W.
Schreiber, S.
Hanauer, S.
Colombel, J.
Bloomfield, R.
Lichtenstein, G.
[J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S14 - S14
[5] Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study
Sandborn, William
Schreiber, Stefan
Hanauer, Stephen
Colombel, Jean-Frederick
Bloomfield, Ralph
Lichtenstein, Gary
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S448 - S448
[6] Sustained Remission with No Dose Escalation after Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 1-Year Results from PRECiSE 4
Sandborn, William
Rubin, David
Sen, David
Feagan, Brian
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S439 - S439
[7] Remission Rates in Crohn's Disease Patients Treated With a Re-Induction Regimen of Certolizumab Pegol After Experiencing Disease Exacerbation: 7 Year Results From the Precise 4 Study
Lee, Scott D.
Schreiber, Stefan
Schwartz, David A.
Burakoff, Robert
Binion, David G.
Kayhan, Cem
Kosutic, Gordana
Ambarkhane, Sumeet
Sen, David
Hasan, Iram
Spearman, Marshall
Sandborn, William
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S261 - S261
[8] RE-induction and maintenance therapy with subcutaneous certolizumab pegial in patients with Crohn's disease following treatment failure: Precise 4 results
Sandborn, William J.
Hanauer, Stephen B.
Rutgeerts, Paul J.
Colombel, Jean-frederic
Schreiber, Stefan
[J]. GASTROENTEROLOGY, 2007, 132 (04) : A505 - A505
[9] Long-Term Remission With Certolizumab Pegol in Crohn's Disease: Efficacy Over 5 Years in Patients With No Prior Anti-TNF Agent Exposure (PRECiSE 3 Study)
Sandborn, William J.
Schwartz, David A.
Schreiber, Stefan
Lawrance, Ian C.
Sen, David I.
Lichtenstein, Gary R.
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S262 - S262
[10] Long-term remission with certolizumab pegol in Crohn's disease: Efficacy over 5 years in patients with no prior anti-TNF agent exposure (precise 3 study)
Sandborn, William J.
Schwartz, David
Schreiber, Stefan
Lawrance, Ian C.
Sen, David
Lichtenstein, Gary R.
[J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S23 - S23

← 1 2 3 →